SciELO - Scientific Electronic Library Online

 
vol.66 issue3Omalizumab as an adjuvant therapy for treating severe atopic dermatitis in children. A serie of cases author indexsubject indexsearch form
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista alergia México

On-line version ISSN 2448-9190

Abstract

SARANZ, Ricardo et al. Comparative analysis of the exhaled nitric oxide in children and teenagers with allergic and non-allergic rhinitis. Rev. alerg. Méx. [online]. 2019, vol.66, n.3, pp.272-281.  Epub Feb 19, 2020. ISSN 2448-9190.  https://doi.org/10.29262/ram.v66i3.583.

Background:

There is subclinical bronchial inflammation in patients with allergic rhinitis (AR). There is less evidence of inflammation of the lower airway in non-allergic rhinitis (NAR).

Objective:

To investigate the inflammation of the lower airway by exhaled nitric oxide (FeNO) in patients with AR and NAR without asthma and its link to lung function, the severity of rhinitis, and biomarkers of atopy.

Methods:

A cross-sectional study of patients aged 6 to 18 years, with AR or NAR without asthma. Spirometry, serum IgE, blood eosinophil count and FeNO were carried out. Rhinitis was classified according to the ARIA guide.

Results:

Forty patients were included; 28 with AR and 12 with NAR. Patients with AR showed higher FeNO levels (medium 36.5 ppb; range 5-114) than those with NAR (medium 7 ppb; range 5-24) (p = 0.0011). Elevated FeNO was linked to spirometric abnormalities [OR= 7.14 (95 % CI 1.04-49.04), p = 0.049)]. In AR, there was correlation between FeNO and blood eosinophils (r = 0.41, p = 0-33).

Conclusions:

Both children and teenagers with AR showed higher FeNO than patients with NAR, which was correlated with blood eosinophilia and altered lung function.

Keywords : Rhinitis; Inflammation; Spirometry; Exhaled nitric oxide.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )